eMIMSelite: iPhone vs Android
eMIMSelite by MIMS PTE. LTD. is on both the App Store and Google Play. Here are both versions together: downloads, users, revenue, ratings and chart positions, store by store with totals.
Rating
3.7 ★
3.1k ratings, both stores
Measured
Best rank now
#64
Android · 
Medical Free
Medical FreeMeasured
App Store
App details
App ID
6477411434
Publisher
MIMS PTE. LTD.
Publisher country
Singapore 119968
On the store since
Feb 2024
2 years on the store
Minimum OS
iOS 16.0+
iPhone 8 and later
Devices
iPhone · iPad
Universal purchase
Content rating
17+
1 content note below
Languages
1
EN
Size
50 MB
Also listed in
Education
Content notesFrequent/Intense Medical/Treatment Information
Google Play
App details
App ID
id.mimsconsult.mims.com
Publisher
MIMS PTE. LTD.
Publisher country
Singapore 119968
Content rating
Everyone
eMIMSelite downloads & installs
Both stores, worldwide. Bands are open; exact numbers are free with an account.
| Store | Downloads / day | Lifetime installs |
|---|---|---|
| iPhone | – | – |
| Google Play | 50+ | 100k+ Measured |
| Total | 50+ Confidence | 100k+ Confidence |
How this is calculated
iPhone: chart positions and rating growth per country, anchored on its own Android downloads; lifetime from ratings worldwide × installs per rating. Google Play: the daily change in its exact install count. The total adds every store.
Where eMIMSelite's downloads come from Modelled
Last 30 days: organic search, browsing the store, features and paid ads.
Active users
All platforms, worldwide. Free with an account.
Stickiness (DAU / MAU)
how many monthly users open it on a given day
How this is calculated
Monthly users come from lifetime installs across every store, fitted on monthly active user figures companies publish; daily users = monthly × the typical daily/monthly ratio for the category. Confidence is the chance the real number is within half to double ours.
Business model: Ad-led
How eMIMSelite makes money: subscriptions, one-off purchases and ads.
Ads
Ads
/mo
of revenue
Where it ranks now
Both stores, across every country we track.
Ratings
Both stores. Store data, measured.
| Store | Rating | Ratings |
|---|---|---|
| App Store | 2.6 ★ | 18 |
| Google Play | 3.7 ★ | 3.1k 76 written reviews |
| Both stores | 3.7 ★ weighted by ratings | 3.1k |
About eMIMSelite
MIMS Australia introduces eMIMSelite, a premium medicine reference subscription designed to support healthcare professionals in delivering high-quality patient care, even in offline environments.
eMIMSelite offers extensive, validated information on all registered medicines in Australia, along with specialised content including drug-disease contraindications, safe administration of IV injectables, sports medicine, and dental monographs.
Key features include:
Offline access ensuring uninterrupted use regardless of internet connectivity.
Advanced authentication and integration with organizational libraries.
Rapid search and retrieval of product information, consumer medicine information, product images, drug interactions, and PBS data.
MIMS Interaction Checker to identify:
a. Potentially harmful combinations of medicines
b. Medicines that may be unsuitable due to the patient’s allergy profile
c. Medicines that may be unsuitable due to a health condition
Easy access to need-to-know information on medicine and solution compatibility for safe administration of IV injectable medicines.
Access essential dental-specific medicine information such as effects on dental treatment, recommendations for dental patients, and more.
Identify potentially prohibited medications in and out of competition based on the World Anti Doping Agency (WADA) list.
Premium Tool, Specialized Curated Content
Disclaimer: eMIMSelite is strictly meant to be used by Healthcare Professionals – Doctors, Nurses, Pharmacists & Medical Students.
For more information: https://emims.plus/emimselite/
To access the platform: https://app.emims.plus/signup
For Support:
Email: [email protected]
Phone: 1800 800 629
Available: Monday – Friday, 9:00 AM – 5:00 PM AEST
eMIMSelite offers extensive, validated information on all registered medicines in Australia, along with specialised content including drug-disease contraindications, safe administration of IV injectables, sports medicine, and dental monographs.
Key features include:
Offline access ensuring uninterrupted use regardless of internet connectivity.
Advanced authentication and integration with organizational libraries.
Rapid search and retrieval of product information, consumer medicine information, product images, drug interactions, and PBS data.
MIMS Interaction Checker to identify:
a. Potentially harmful combinations of medicines
b. Medicines that may be unsuitable due to the patient’s allergy profile
c. Medicines that may be unsuitable due to a health condition
Easy access to need-to-know information on medicine and solution compatibility for safe administration of IV injectable medicines.
Access essential dental-specific medicine information such as effects on dental treatment, recommendations for dental patients, and more.
Identify potentially prohibited medications in and out of competition based on the World Anti Doping Agency (WADA) list.
Premium Tool, Specialized Curated Content
Disclaimer: eMIMSelite is strictly meant to be used by Healthcare Professionals – Doctors, Nurses, Pharmacists & Medical Students.
For more information: https://emims.plus/emimselite/
To access the platform: https://app.emims.plus/signup
For Support:
Email: [email protected]
Phone: 1800 800 629
Available: Monday – Friday, 9:00 AM – 5:00 PM AEST
eMIMSelite iPhone
Not in any tracked top chart right now.
Updated 24 Oct 2026 · rankings refresh through the day
DeveloperMIMS PTE. LTD.
CategoryMedical
PriceFree
Released
Rating★ 2.6 (18)
Version1.6.2
Age rating17+
First seen by us
28 Sep 2026
28 Sep 2026Rating
2.6 ★
18 ratings
Measured
eMIMSelite on the App Store
App details
App ID
6477411434
Publisher
MIMS PTE. LTD.
Publisher country
Singapore 119968
On the store since
Feb 2024
2 years on the store
Minimum OS
iOS 16.0+
iPhone 8 and later
Devices
iPhone · iPad
Universal purchase
Content rating
17+
1 content note below
Languages
1
EN
Size
50 MB
Also listed in
Education
Content notesFrequent/Intense Medical/Treatment Information
eMIMSelite downloads
Worldwide, per day, and installs to date. The band is open; the exact number is free with an account.
How this is calculated
Apple publishes no download counts. iPhone downloads come from chart positions and daily rating growth per country, calibrated on Google Play install counts; lifetime installs from ratings worldwide × installs per rating. Confidence is the chance the real number is within half to double ours.
Where eMIMSelite's downloads come from Modelled
Last 30 days: organic search, browsing the store, features and paid ads.
Active users
All platforms, worldwide. Free with an account.
Stickiness (DAU / MAU)
how many monthly users open it on a given day
How this is calculated
Monthly users come from lifetime installs across every store, fitted on monthly active user figures companies publish; daily users = monthly × the typical daily/monthly ratio for the category. Confidence is the chance the real number is within half to double ours.
Business model: Ad-led
How eMIMSelite makes money: subscriptions, one-off purchases and ads.
Ads
Ads
/mo
of revenue
Where it ranks now
Every top chart it appears in across 30 countries.
| Country | Charts | Rank |
|---|---|---|
| Not charting right now. | ||
Ratings
App Store, worldwide.
Rating
2.6 ★
18 ratings
Measured
Ratings
18
Measured
About eMIMSelite
MIMS Australia introduces eMIMSelite, a premium medicine reference subscription designed to support healthcare professionals in delivering high-quality patient care, even in offline environments.
eMIMSelite offers extensive, validated information on all registered medicines in Australia, along with specialised content including drug-disease contraindications, safe administration of IV injectables, sports medicine, and dental monographs.
Key features include:
Offline access ensuring uninterrupted use regardless of internet connectivity.
Advanced authentication and integration with organizational libraries.
Rapid search and retrieval of product information, consumer medicine information, product images, drug interactions, and PBS data.
MIMS Interaction Checker to identify:
a. Potentially harmful combinations of medicines
b. Medicines that may be unsuitable due to the patient’s allergy profile
c. Medicines that may be unsuitable due to a health condition
Easy access to need-to-know information on medicine and solution compatibility for safe administration of IV injectable medicines.
Access essential dental-specific medicine information such as effects on dental treatment, recommendations for dental patients, and more.
Identify potentially prohibited medications in and out of competition based on the World Anti Doping Agency (WADA) list.
Premium Tool, Specialized Curated Content
Disclaimer: eMIMSelite is strictly meant to be used by Healthcare Professionals – Doctors, Nurses, Pharmacists & Medical Students.
For more information: https://emims.plus/emimselite/
To access the platform: https://app.emims.plus/signup
For Support:
Email: [email protected]
Phone: 1800 800 629
Available: Monday – Friday, 9:00 AM – 5:00 PM AEST
eMIMSelite offers extensive, validated information on all registered medicines in Australia, along with specialised content including drug-disease contraindications, safe administration of IV injectables, sports medicine, and dental monographs.
Key features include:
Offline access ensuring uninterrupted use regardless of internet connectivity.
Advanced authentication and integration with organizational libraries.
Rapid search and retrieval of product information, consumer medicine information, product images, drug interactions, and PBS data.
MIMS Interaction Checker to identify:
a. Potentially harmful combinations of medicines
b. Medicines that may be unsuitable due to the patient’s allergy profile
c. Medicines that may be unsuitable due to a health condition
Easy access to need-to-know information on medicine and solution compatibility for safe administration of IV injectable medicines.
Access essential dental-specific medicine information such as effects on dental treatment, recommendations for dental patients, and more.
Identify potentially prohibited medications in and out of competition based on the World Anti Doping Agency (WADA) list.
Premium Tool, Specialized Curated Content
Disclaimer: eMIMSelite is strictly meant to be used by Healthcare Professionals – Doctors, Nurses, Pharmacists & Medical Students.
For more information: https://emims.plus/emimselite/
To access the platform: https://app.emims.plus/signup
For Support:
Email: [email protected]
Phone: 1800 800 629
Available: Monday – Friday, 9:00 AM – 5:00 PM AEST
Latest updates
1.6.2
Updated the National Immunisation Program Schedule to reflect the latest recommendations. Improved reliability of offline database updates and resolved issues affecting the Medicines In Pregnancy search and Dental Medicines Information modules. Enhanced overall app stability and performance.
More from MIMS PTE. LTD.
MIMS - Drug, Disease, News Android
MIMS - Drug, Disease, News is #64 in Medical Free on Google Play in Indonesia and charting in 1 of 23 countries we track.
Updated 24 Oct 2026 · rankings refresh through the day
DeveloperMIMS
CategoryMedical
PriceFree
Released
Installs100k+
Rating★ 3.7 (3.1k)
Updated–
Content ratingEveryone
Rating
3.7 ★
3.1k ratings
Measured
Best rank now
#64
Medical FreeMeasured
MIMS - Drug, Disease, News on Google Play
App details
App ID
id.mimsconsult.mims.com
Publisher
MIMS PTE. LTD.
Publisher country
Singapore 119968
Content rating
Everyone
MIMS - Drug, Disease, News downloads
Worldwide, per day, and installs to date. The band is open; the exact number is free with an account.
How this is calculated
Google Play shows an exact lifetime install count; downloads per day are its daily change (measured). When Play hasn't refreshed the count, they come from new ratings and Top Free chart positions. Confidence is the chance the real number is within half to double ours.
Where MIMS - Drug, Disease, News's downloads come from Modelled
Last 30 days: organic search, browsing the store, features and paid ads.
Active users
All platforms, worldwide. Free with an account.
Stickiness (DAU / MAU)
how many monthly users open it on a given day
How this is calculated
Monthly users come from lifetime installs across every store, fitted on monthly active user figures companies publish; daily users = monthly × the typical daily/monthly ratio for the category. Confidence is the chance the real number is within half to double ours.
Business model: Ad-led
How MIMS - Drug, Disease, News makes money: subscriptions, one-off purchases and ads.
Ads
Ads
/mo
of revenue
Where it ranks on Google Play
Every top 200 chart it appears in across 23 countries.
| Country | Charts | Rank |
|---|---|---|
| Indonesia | MedicalFree | #64 |
Apps near MIMS - Drug, Disease, News on the chart
Medical Free, around #64.
Ratings
Google Play, worldwide.
Rating
3.7 ★
3.1k ratings
Measured
Ratings
3.1k
Measured
Written reviews
76
Measured
About MIMS - Drug, Disease, News
For over 50 years, MIMS has provided trusted and relevant clinical information for over two million healthcare professionals in Asia. Designed for busy individuals on the go, the MIMS app is a convenient one-stop clinical reference that provides healthcare professionals with the clinical decision support they need at the point of care.
The MIMS Mobile app for Android™/ IOS™ is available for free.
For more information, visit www.mims.com/mobile-app
---------------------------------------------------------------------------------------------------------------------------------------------
Key features available in our app:
Drug Information
• Search for drug dosing information or specific drug interactions, and find the answers you need in seconds with our concise and comprehensive drug database.
• Based on locally-approved prescribing information, drug monographs are written and kept up-to-date by licensed healthcare professionals.
Disease & Condition Management Guidelines
• Voted most valuable online clinical resource by doctors in Asia.
• Review up-to-date disease management guidelines and be assured of reliable content fully substantiated by validated references and internationally-recognised researches, to enable you to make better-informed prescribing decisions.
Medical News & CME Updates
• Read the latest news available across various specialties in Asia through our renowned publications (Medical Tribune, JPOG, Oncology Tribune, etc), and keep your knowledge and skills current with changes in medicine.
Multimedia
• The MIMS award-winning medical multimedia series is now accessible from the app.
• Watch insightful video interviews focusing on treatment options, disease management and latest updates by experts from various specialties, and upgrade your medical knowledge.
If you have any feedback for us, you are welcome to email us at [email protected]
We would love to hear from you.
The MIMS Mobile app for Android™/ IOS™ is available for free.
For more information, visit www.mims.com/mobile-app
---------------------------------------------------------------------------------------------------------------------------------------------
Key features available in our app:
Drug Information
• Search for drug dosing information or specific drug interactions, and find the answers you need in seconds with our concise and comprehensive drug database.
• Based on locally-approved prescribing information, drug monographs are written and kept up-to-date by licensed healthcare professionals.
Disease & Condition Management Guidelines
• Voted most valuable online clinical resource by doctors in Asia.
• Review up-to-date disease management guidelines and be assured of reliable content fully substantiated by validated references and internationally-recognised researches, to enable you to make better-informed prescribing decisions.
Medical News & CME Updates
• Read the latest news available across various specialties in Asia through our renowned publications (Medical Tribune, JPOG, Oncology Tribune, etc), and keep your knowledge and skills current with changes in medicine.
Multimedia
• The MIMS award-winning medical multimedia series is now accessible from the app.
• Watch insightful video interviews focusing on treatment options, disease management and latest updates by experts from various specialties, and upgrade your medical knowledge.
If you have any feedback for us, you are welcome to email us at [email protected]
We would love to hear from you.